X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
male (12) 12
humans (11) 11
middle aged (11) 11
adult (10) 10
infectious diseases (10) 10
aged (9) 9
colistin (9) 9
female (9) 9
health aspects (7) 7
microbiology (6) 6
young adult (6) 6
adolescent (5) 5
aged, 80 and over (5) 5
anti-bacterial agents - therapeutic use (5) 5
gram-negative bacteria (5) 5
internal medicine (5) 5
mortality (5) 5
critically-ill patients (4) 4
drug resistance (4) 4
drug resistance, multiple, bacterial (4) 4
heart (4) 4
immunology (4) 4
infective endocarditis (4) 4
medicine, general & internal (4) 4
meropenem (4) 4
transplantation (4) 4
acinetobacter baumannii (3) 3
acinetobacter baumannii - drug effects (3) 3
analysis (3) 3
colistin - therapeutic use (3) 3
combination therapy (3) 3
endocarditis (3) 3
heart transplant (3) 3
incidence (3) 3
infections (3) 3
infectious disease (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
medicine & public health (3) 3
mutation (3) 3
prognosis (3) 3
therapy (3) 3
treatment outcome (3) 3
acinetobacter (2) 2
acinetobacter baumannii - isolation & purification (2) 2
acinetobacter infections - drug therapy (2) 2
anti-infective agents (2) 2
bacteria (2) 2
bacterial infections (2) 2
blood-stream infections (2) 2
cardiac patients (2) 2
care and treatment (2) 2
case-control studies (2) 2
clinical medicine (2) 2
clinical trials (2) 2
cohort studies (2) 2
combination (2) 2
disease (2) 2
drug therapy (2) 2
embolism (2) 2
endocarditis - complications (2) 2
follow-up studies (2) 2
heart transplantation (2) 2
heart transplantation - adverse effects (2) 2
heart valve prostheses (2) 2
hospitalization (2) 2
immunocompromised host (2) 2
immunosuppression (2) 2
immunosuppressive agents - adverse effects (2) 2
infectious medicine (2) 2
infektionsmedicin (2) 2
intravenous colistin (2) 2
klebsiella-pneumoniae (2) 2
klinisk medicin (2) 2
management (2) 2
medical research (2) 2
medicine, experimental (2) 2
microbial sensitivity tests (2) 2
multicenter (2) 2
nosocomial infection (2) 2
organ transplant recipients (2) 2
outcomes (2) 2
patient outcomes (2) 2
population pharmacokinetics (2) 2
predictors (2) 2
prevalence (2) 2
prevalence studies (2) 2
prospective studies (2) 2
prosthesis-related infections (2) 2
retrospective studies (2) 2
risk (2) 2
risk factors (2) 2
safety (2) 2
solid-organ transplantation (2) 2
thrombosis (2) 2
transplant recipients (2) 2
virology (2) 2
1506 (1) 1
1706 (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 8/2013, Volume 57, Issue 3, pp. 349 - 358
Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious infections in critically ill patients. Colistin often remains the only... 
Intensive care units | Health outcomes | Acinetobacter baumannii | Microbial sensitivity tests | Mortality | Acinetobacter | Infections | Hospitalization | ARTICLES AND COMMENTARIES | Dosage | Arm | Treatment efficacy | Ventilator-associated pneumonia | Antimicrobial therapy | Treatment safety | INFECTIOUS DISEASES | MULTIDRUG-RESISTANT | ventilator-associated pneumonia | antimicrobial therapy | MICROBIOLOGY | IMMUNOLOGY | ATTRIBUTABLE MORTALITY | NOSOCOMIAL INFECTIONS | treatment safety | GRAM-NEGATIVE BACTERIA | GLOBAL SPREAD | mortality | MULTIRESISTANT | MOLECULAR EPIDEMIOLOGY | INTRAVENOUS COLISTIN | CRITICALLY-ILL PATIENTS | treatment efficacy | NEPHROTOXICITY | Length of Stay | Intensive Care Units | Tertiary Care Centers | Humans | Middle Aged | Acinetobacter Infections - drug therapy | Critical Illness | Male | Treatment Outcome | Acinetobacter Infections - mortality | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - methods | Drug Resistance, Multiple, Bacterial | Survival Analysis | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Colistin - therapeutic use | Female | Rifampin - therapeutic use | Aged | Acinetobacter baumannii - drug effects | Usage | Colistin | Patient outcomes | Dosage and administration | Drug therapy, Combination | Drug therapy | Rifampin | Health aspects
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 04/2018, Volume 18, Issue 4, pp. 391 - 400
Journal Article
CLINICAL MICROBIOLOGY AND INFECTION, ISSN 1198-743X, 08/2019, Volume 25, Issue 8, pp. 943 - 950
Background: Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has... 
INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | Colistin | Mortality | MICROBIOLOGY | Extensively drug-resistant | COMBINATION | Ceftazidime-avibactam | Ertapenem | Fosfomycin | GRAM-NEGATIVE BACTERIA | IMIPENEM-CILASTATIN | DOUBLE-BLIND | Clinical failure | Meropenem | Tigecycline | CRITICALLY-ILL PATIENTS | Klebsiella pneumoniae | KLEBSIELLA-PNEUMONIAE
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 02/2018, Volume 20, Issue 1, pp. e12813 - n/a
Journal Article
Journal Article
BMJ Open, ISSN 2044-6055, 04/2016, Volume 6, Issue 4, p. e009956
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2016, Volume 48, Issue 1, pp. 61 - 68
Journal Article
Journal Article
Medicine (United States), ISSN 0025-7974, 2016, Volume 95, Issue 39, p. e4972
Blood coagulation plays a key role in the pathogenesis of infective endocarditis (IE). Conditions associated with thrombophilia could enhance IE vegetation... 
Infective |